Filing Flows › Comparisons › NWBO vs BIOE
Northwest Biotherapeutics vs Bio Essence: NWBO and BIOE compared
Northwest Biotherapeutics is the larger company: $807K of revenue in its latest quarter (Q2 2026) against $795K for Bio Essence (Q2 2026). Northwest Biotherapeutics is growing faster (+516% against +207% a year earlier).
Where the money goes: NWBO and BIOE
Northwest Biotherapeutics (NWBO) · Q2 2026
Northwest Biotherapeutics, Q2 2026: revenue $807K (+516% year over year), net loss $15.4M, operating cash flow −$7.2M. The chart follows the revenue to costs, profit and cash.
Bio Essence (BIOE) · Q2 2026
Bio Essence, Q2 2026: revenue $795K (+207% year over year), operating margin 35.1%, net earnings $270K, operating cash flow $60K. The chart follows the revenue to costs, profit and cash.
| Northwest Biotherapeutics (NWBO) | Bio Essence (BIOE) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $807K | $795K |
| Revenue growth, Y/Y | +516% | +207% |
| Gross margin | — | 59.2% |
| Operating margin | n/m | 35.1% |
| Net earnings | −$15.4M | $270K |
| Net margin | — | 34.0% |
| Operating cash flow | −$7.2M | $60K |
Questions
Which is bigger, Northwest Biotherapeutics or Bio Essence?
Northwest Biotherapeutics is the larger company: $807K of revenue in its latest quarter (Q2 2026) against $795K for Bio Essence (Q2 2026).
Is Northwest Biotherapeutics or Bio Essence growing faster?
Northwest Biotherapeutics is growing faster (+516% against +207% a year earlier).
More: Northwest Biotherapeutics earnings · how Northwest Biotherapeutics makes money · Bio Essence earnings · how Bio Essence makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.